Pronađeno: 1-9 / 9 radova

Autori: Tiede Andreas

>> Filter: Samo Article i Review

>> Sve godine

Naslov Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A (Article)
Autori Tiede Andreas Rosa Cid Ana Goldmann Georg Jimenez-Yuste Victor Pluta Michael Lissitchkov Toshko May Marcus Matytsina Irina Miljic Predrag S Pabinger Ingrid Persson Paula 
Info THROMBOSIS AND HAEMOSTASIS, (2020), vol. 120 br. 2, str. 277-288
Projekat Novo Nordisk A/S (Bagsvaerd, Denmark)Novo Nordisk
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov A New Dosing Model Based on Body Mass Index to Guide Factor VIII Dosing in Patients with Hemophilia A (Meeting Abstract)
Autori Tiede Andreas Goldmann Georg Miljic Predrag S Korsholm Lars Matytsina Irina Persson Paula Jelev Lissitchkov Toshko 
Info BLOOD, (2018), vol. 132 br. , Suppl. 1, str. -
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial (Article)
Autori Lentz Steven R Janic Dragana M  Kavakli Kaan Miljic Predrag S Oldenburg Johannes Ozelo Margareth Castro Santagostino Elena Suzuki Takashi Zupancic-Salek Silva Korsholm Lars Matytsina Irina Tiede Andreas 
Info HAEMOPHILIA, (2018), vol. 24 br. 6, str. E391-E394
Projekat Novo Nordisk A/S
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2 (Meeting Abstract)
Autori Tiede Andreas Janic Dragana M  Ozelo M Santagostino E Korsholm Lars Matytsina Irina Lentz SR 
Info HAEMOPHILIA, (2018), vol. 24 br. , Suppl. S1, str. 52-52
Projekat Alnylam; Baxter/Baxalta/Shire; Bayer; Biogen Idec; Biotest; CSL Behring; Novo Nordisk A/S; Octapharma; Pfizer; Roche; Sobi; Baxter; Shire
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Interim results from a large multinational extension trial (guardian (TM) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A (Letter)
Autori Lentz SR Cerqueira MH Janic Dragana M  Kempton CL Matytsina Irina Misgav M Oldenburg J Ozelo M Recht M Rosholm A Savic Aleksandar D  Suzuki Takashi Tiede Andreas Santagostino E 
Info HAEMOPHILIA, (2016), vol. 22 br. 5, str. E445-E449
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Efficacy and safety of turoctocog alfa for prophylaxis and treatment of bleeding episodes in patients with severe hemophilia A: results from the guardian (TM) 2 trial (Meeting Abstract)
Autori Janic Dragana M  Karim Faraizah Abdul Matytsina Irina Ozelo Margareth Castro Savic Aleksandar D  Tiede Andreas Oldenburg Johannes 
Info HAEMOPHILIA, (2016), vol. 22 br. , Suppl. 4, str. 48-48
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Interim results from a large multinational extension trial (Guardian TM2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A (Meeting Abstract)
Autori Lentz SR Kempton CL Janic Dragana M  Savic Aleksandar D  Cerqueira MH Ozelo MC Recht M Oldenburg J Tiede Andreas Suzuki Takashi Matytsina Irina Zeuthen N Santagostino E 
Info JOURNAL OF THROMBOSIS AND HAEMOSTASIS, (2015), vol. 13 br. , Suppl. 2, str. 842-842
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Results from a large multinational clinical trial (guardian (TM) 1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy (Article)
Autori Lentz SR Misgav M Ozelo MC Salek SZ Veljkovic Dobrila K Recht M Cerqueira MH Tiede Andreas Brand B Mancuso ME Seremetis S Lindblom A Martinowitz U 
Info HAEMOPHILIA, (2013), vol. 19 br. 5, str. 691-697
Projekat Novo Nordisk A/S (Bagsvaerd, Denmark)
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Safety and efficacy of turoctocog alfa during prevention and treatment of bleeds in adult and adolescent patients with severe haemophilia A (Meeting Abstract)
Autori Lentz SR Misgav M Ozelo MC Zupancic-Salek Silva Veljkovic Dobrila K Recht M Cerqueira MH Tiede Andreas Brand B Mancuso ME Martinowitz U 
Info HAEMOPHILIA, (2012), vol. 18 br. 5, str. 829-830
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX